Calls Purchased on BioMimetic Therapeutics, Inc. (BMTI)

Shares of BioMimetic Therapeutics, Inc. BMTI are lower on the session by 2.44%, currently trading at $12.80. The stock has been moving largely sideways over the past four months and is currently trading above the 200-day moving average. Options traders are buying calls on the name today. A short while ago the May 2011 $15.00 call was purchased 1,400 times, on the offer, on open interest of 2,738 contracts. Overall call volume is now running at 3.22x the daily average with 72% of all calls traded being purchases on the offer. BioMimetic Therapeutics, Inc. is a biotechnology company, which develops and commercializes products to help stimulate the body's natural tissue regenerative process.